| Parent Terms |
Term With Siblings |
Child Terms |
|
|
(2S)-3-(3-pyridyl)propyl 1-(3,3-dimethyl-1,2-dioxopentyl)pyrrolidine-2-carboxylate
(2S,4R)-1-acetyl-N-[(1S)-4-[(aminoiminomethyl)amino]-1-(benzothiazol-2-ylcarbonyl)butyl]-4-hydroxypyrrolidine-2-carboxamide
(3S,4S)-3,4-dihydroxy-L-proline
(5S)-5-(carboxymethyl)-L-proline
(R)-4-hydroxy-1-methyl-L-proline
(S)-timolol (anhydrous) +
1-[(2R)-2-amino-2-cyclohexylacetyl]-N-\{5-chloro-2-[2-(ethylamino)-2-oxoethoxy]benzyl\}-L-prolinamide
1-[3,3-dimethyl-2-(2-2-methylaminopropionylamino)butyryl]-4-phenoxypyrrolidine-2-[N-(1,2,3,4-tetrahydronaphthalen-1-yl)]carboxamide
1-\{[1-(2-amino-3-phenylpropionyl)pyrrolidine-2-carbonyl]amino\}-2-(3-cyanophenyl)ethaneboronic acid
2-hydroxy-17beta-estradiol +
2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine
2-O-acetyl-1-O-octadecyl-sn-glycero-3-phosphocholine
3-[4-(3-chlorophenyl)piperazin-1-yl]-1,1-diphenylpropan-2-ol hydrochloride
4-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)pyrrolo[1,2-a]quinoxaline dimaleate
4-O-(beta-L-Araf)-cis-L-Hyp
4-O-(beta-L-Araf-(1->2)-beta-L-Araf-(1->2)-beta-L-Araf)-cis-L-Hyp
5-aminolevulinic acid hydrochloride
5-oxo-L-proline 2-naphthylamide
6-O-galloyl-beta-D-glucose
[(R)-1-L-prolylpyrrolidin-2-yl]boronic acid
\{(2S,3S,4S)-2-carboxy-4-[(1Z,3E,5R)-5-carboxy-1-methylhexa-1,3-dienyl]pyrrolidin-3-yl\}acetic acid
alpha-methyl-L-dopa ethyl ester
alpha-N-dichloroacetyl-p-aminophenylserinol
amlodipine benzenesulfonate +
angiotensin (1-9) dizwitterion
bambuterol hydrochloride +
beclomethasone dipropionate
beta-phenyl-D-phenylalanyl-N-(2,5-dichlorobenzyl)-L-prolinamide
betaxolol hydrochloride +
bevantolol hydrochloride +
carmoxirole hydrochloride
cefotiam hexetil dihydrochloride
ceftaroline fosamil acetate +
ceftaroline fosamil acetate monohydrate
clorazepate monopotassium +
colforsin daropate hydrochloride
dabigatran etexilate methanesulfonate
dorzolamide hydrochloride
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor +
enalaprilat (anhydrous) +
eprosartan methanesulfonate
ethyl (5Z,8Z,11Z,14Z,17Z)-icosapentaenoate
fasudil hydrochloride hydrate
fosaprepitant dimeglumine
fosinopril A phosphinate ester-containing N-acyl derivative of (4S)-cyclohexyl-L-proline. It is used for the treatment of hypertension and heart failure. A pro-drug, it is hydrolysed in vivo to the corresponding phosphininc acid, fosinoprilat, which is the active metabolite.
guanethidine monosulfate +
hydralazine hydrochloride
irinotecan hydrochloride (anhydrous) +
irinotecan hydrochloride hydrate
isopropyl methylphosphonofluoridate +
L-hydroxyproline 2-naphthylamide
L-proline 2-naphthylamide
methyl 1-methyl-5-oxo-L-prolinate
methyl 5-aminolevulinate +
methyl 5-aminolevulinate hydrochloride
methylprednisolone suleptanate
metipranolol hydrochloride
metronidazole hydrochloride
N(1),N(8)-bis-(dihydrocaffeoyl)spermidine
N-(2,4-dinitrophenyl)-L-proline
N-[4-(morpholin-4-ylcarbonyl)benzoyl]-L-valyl-N-[(3S)-5,5,6,6,6-pentafluoro-2-methyl-4-oxohexan-3-yl]-L-prolinamide
N-allyl-1-phenyl-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol hydrobromide
N-allyl-6-chloro-1-(3-methylphenyl)-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol hydrobromide
N-benzyloxycarbonyl-L-prolyl-L-prolinal
N-ethoxycarbonyl-D-phenylalanylprolyl-2-(4-aminobutyl)hydrazine
N-methyl-6-chloro-1-(3-methylphenyl)-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol hydrobromide
N-methylquipazine dimaleate
nebivolol hydrochloride +
prednisolone sodium phosphate
quercetin 3-O-alpha-(6'''-caffeoylglucosyl-beta-1,2-rhamnoside)
rilpivirine hydrochloride +
tenofovir alafenamide fumarate +
tenofovir disoproxil fumarate
|
|
 |
| Synonyms |
| Exact Synonyms: |
(4S)-4-cyclohexyl-1-({[2-methyl-1-(propanoyloxy)propoxy](4-phenylbutyl)phosphoryl}acetyl)-L-proline
|
| Related Synonyms: |
(2S,4S)-4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid
;
(2S,4S)-4-cyclohexyl-1-{2-[(2-methyl-1-propionyloxy-propoxy)-(4-phenyl-butyl)-phosphinoyl]-acetyl}-pyrrolidine-2-carboxylic acid
;
(S)-4-Cyclohexyl-1-{2-[(2-methyl-1-propionyloxy-propoxy)-(4-phenyl-butyl)-phosphinoyl]-acetyl}-pyrrolidine-2-carboxylic acid
;
Formula=C30H46NO7P
;
InChI=1S/C30H46NO7P/c1-4-28(33)37-30(22(2)3)38-39(36,18-12-11-15-23-13-7-5-8-14-23)21-27(32)31-20-25(19-26(31)29(34)35)24-16-9-6-10-17-24/h5,7-8,13-14,22,24-26,30H,4,6,9-12,15-21H2,1-3H3,(H,34,35)/t25-,26+,30?,39?/m1/s1
;
InChIKey=BIDNLKIUORFRQP-FKDWWROVSA-N
;
SMILES=[H][C@]1(C[C@H](N(C1)C(=O)CP(=O)(CCCCc1ccccc1)OC(OC(=O)CC)C(C)C)C(O)=O)C1CCCCC1
|
| Alternate IDs: |
CHEBI:159901
;
CHEBI:288733
|
| Xrefs: |
Beilstein:8176492
;
CAS:98048-97-6
;
DrugBank:DB00492
;
KEGG:C07016
;
KEGG:D07992
;
LINCS:LSM-6485
|
| Xref Mesh: |
MESH:D017328
|
| Xrefs: |
PMID:11937741
;
PMID:18209565
;
PMID:22729889
;
PMID:8285178
;
PMID:9195116
;
Patent:CN101367839
;
Patent:EP2264039
;
Patent:US2010297711
;
Patent:US4337201
|
| Cyclic Relationships: |
is_conjugate_acid_of CHEBI:59125 |
|
